• By ICR Secretariat
  • Posted Wednesday, April 10, 2019

Brexit will have ‘minimal’ effect on R&D in UK, says expert

http://www.pharmatimes.com/news/brexit_will_have_minimal_effect_on_r_and_d_in_uk,_says_expert_1283463

Despite Brexit uncertainties, the future for UK research and development (R&D), specifically clinical trials, is looking promising, heard delegates at the ‘Brexit: What's Next for Pharma?’ Pharmaceutical Industry Network Group (PING) conference in Hatfield, UK, this week.